The global specialty enzymes market is expected to grow at a compound annual growth rate of 9.08% over the forecast period to reach a market size of US$5.144 billion in 2027 up from US$2.280 billion in 2020.
Enzymes are biocatalyst proteins. Enzymes bind to and function as a substratum for molecules. The conversion of the substrates into distinct molecules occurs using an enzyme known as a product. The reaction rate is improved by the use of the catalyst. A biocatalyst is a micro-organism-generated enzyme that is environmentally friendly. The enzymes, in particular, differ from traditional enzymes. Specialty enzymes are the new technology used mostly for the development of new foods. Different industries are also used specialty enzymes. Enzymes such as proteases, lipases, glycosides, hydrolipases, transglutaminases, and many more have been altered. Develops novel enzyme features such as thermal stability and enhances the enzyme activity at low temperatures. The main technologies utilized for developing specialty enzymes are recombinant DNA technology, genetic engineering, and protein engineering. Specific incidents of death, such as cardiovascular diseases, oncogenes, asthma, lysosomal diseases, and pain throughout older age are also analyzed using special enzymes. Also employed for the alteration of DNA are specialty enzymes. Polymerase and nucleases are specialized enzymes used in biology, pharmaceutical industries, and diagnostics. Special enzymes are probiotics used to more efficiently convert food to energy. In tissue replacement and generating new tissue in the body, specialty enzymes are also employed. Due to urbanization and a change in customer choice, specialty enzymes have increased demand in recent years and added favorable market feelings.
The need for specialty enzymes in the global market has increased with changes in metabolism and the increase in the aging population. According to data from the World Bank, the share of the population aged 65 years and above in the total population has increased from 7.57% in 2010 to 9.32% in 2020. The elderly population aged 65 years and above has grown from 523.576 billion in 2010 to 723.184 billion in 2020, growing by more than 38% during the decade. The world market for specialty enzymes is predicted to rise due to developments in biotechnology and research institutes, the pharmaceutical sector, and expansion in the diagnostic sector with the development of green chemistry. Specialty enzymes on the market have increased demand for them due to new technology innovations and trend changes compared to standard enzymes.
However, the market for customized enzymes is mainly concerned with food sensitivities, intolerances, and pH-maintained at operating temperatures. Biotech innovation and the low consumption of chemical enzymes are the main reasons driving the worldwide specialty enzyme market in new diagnostic techniques. Consumers' lack of awareness of the benefits of specific enzymes is also a worldwide market threat.
An increase in health care expenditures has also led to the increased usage of tailored medicines, hence increasing the use of diagnostic tests and genetic sequences. This creates a considerable need for diagnostic testing for specialized enzymes. High competition in the pharmaceutical industry is predicted to significantly boost the global need for customized enzymes throughout the forecast. More investment is also planned to promote the use of specialty enzymes in research and biotechnology during the predicted period in the pharmaceutical industry, for developing new biological pharmaceuticals. In addition, pharmaceutical companies are using biocatalysts more to lower pharmaceutical costs and manufacture cost-effective non-generic medications, another factor that is projected to drive expansion in the worldwide enzyme market. The increased use of specialist enzymes for diseases such as lysosomal disorders, cardiovascular diseases, and cancer therapy also fuels the demand for specialty enzymes.
The COVID-19 pandemic, however, is expected to act as a restraint to this market’s growth considering the disruptions in supply chains and business operations of market players caused by the lockdowns imposed because of the pandemic.
The increasing global demand for coupled inductors has led to the entry of several new players in the global specialty enzymes market. Major market players like Johnson & Johnson Medical Devices, Aesculap, Inc., and Medtronic, among others, have been covered along with their relative competitive strategies.
|Market size value in 2020||US$2.280 billion|
|Market size value in 2027||US$5.144 billion|
|Growth Rate||CAGR of 9.08% from 2020 to 2027|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Type, Source, Application, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Amano Enzyme Inc., BASF SE, Codexis, Sanofi, Novozymes A/S, Nagase & Co. Ltd., Biocatalysts, Kerry Inc., DuPont de Nemours, Inc., Specialty Enzymes & Probiotics|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What will be the specialty enzymes market size by 2027?
A1. The global specialty enzymes market is expected to reach a total market size of US$5.144 billion in 2027.
Q2. What are the growth prospects for the specialty enzymes market?
A2. The specialty enzymes market is expected to grow at a CAGR of 9.08% during the forecast period.
Q3. What is the size of the global specialty enzymes market?
A3. Specialty Enzymes Market was valued at US$2.280 billion in 2020.
Q4. How is the specialty enzymes market segmented?
A4. The global specialty enzymes market has been segmented by type, source, application, and geography.
Q5. What factors are anticipated to drive the specialty enzymes market growth?
A5. High competition in the pharmaceutical industry is predicted to significantly boost the global specialty enzymes market.
Amano Enzyme Inc.
Nagase & Co. Ltd.
DuPont de Nemours, Inc.
Specialty Enzymes & Probiotics
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.